Cambridge Memorial Hospital

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer2 trials
• Lung cancer1 trial
• Obesity1 trial
• Prostate cancer1 trial
• Testicular cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 33 trials
• Phase 2/32 trials
• Phase 21 trial

Status

• Active, not recruiting5 trials
• Recruiting2 trials

Lead sponsor

• Alliance for Clinical Trials in Oncology2 trials
• NRG Oncology2 trials
• Canadian Cancer Trials Group1 trial
• SWOG Cancer Research Network1 trial
• University of Sydney1 trial

Running trials

• Recruiting

  Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

  NCT05812807· Phase 3· Alliance for Clinical Trials in Oncology· Source

  Contact: Skander Ghedira (principal investigator)

• Recruiting

  Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

  NCT05174169· Phase 2/3· NRG Oncology· Source

  Contact: Skander Ghedira (principal investigator)

• Active, not recruiting

  A Study of miRNA 371 in Patients With Germ Cell Tumors

  NCT04435756· SWOG Cancer Research Network· Source

• Active, not recruiting

  Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

  NCT04068103· Phase 2/3· NRG Oncology· Source

• Active, not recruiting

  Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

  NCT03057106· Phase 2· Canadian Cancer Trials Group· Source

• Active, not recruiting

  Breast Cancer WEight Loss Study (BWEL Study)

  NCT02750826· Phase 3· Alliance for Clinical Trials in Oncology· Source

• Active, not recruiting

  Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer

  NCT02446405· Phase 3· University of Sydney· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Triple-negative breast cancer1 recruiting